Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Revenues | $ 343,639 | $ 399,964 | $ 10,258 | |
| Cost of sales | 7,860 | 10,335 | 9,585 | |
| Gross profit | 335,779 | 389,629 | 673 | |
| Operating expenses: | ||||
| Wage and salary expense | 411,411 | 773,739 | 831,419 | 1,469,807 |
| Professional fees | 963,752 | 209,763 | 1,896,304 | 622,613 |
| Accounting and legal expense | 117,815 | 381,683 | 443,993 | 852,508 |
| Technology expense | 7,139 | 21,408 | 22,902 | 83,028 |
| General and administrative | 368,790 | 2,927,764 | 1,443,654 | 4,283,712 |
| Research and development | 1,166,605 | 843,549 | 1,960,589 | 1,418,228 |
| Total operating expenses | 3,035,512 | 5,157,906 | 6,598,861 | 8,729,896 |
| Operating loss | (2,699,733) | (5,157,906) | (6,209,232) | (8,729,223) |
| Non-operating income (expense): | ||||
| Change in fair value of warrant liability | 76,122 | 10,910 | 722,108 | |
| Change in fair value of derivative liability | (662,916) | (59,594) | ||
| Loss on conversion of note payable | (96,646) | |||
| Loss on disposition of subsidiaries | (385,528) | (385,528) | ||
| Interest income | 147,147 | 63,148 | 280,491 | 88,590 |
| Interest expense | (269,785) | (653,493) | (306,804) | (1,324,277) |
| Total non-operating expense | (122,638) | (1,562,667) | (15,403) | (1,055,347) |
| Benefit (provision) for income taxes | ||||
| Net loss | $ (2,822,371) | $ (6,720,573) | $ (6,224,635) | $ (9,784,570) |
| Net loss per common share | ||||
| Basic | $ (0.07) | $ (0.48) | $ (0.16) | $ (0.83) |
| Diluted | $ (0.07) | $ (0.48) | $ (0.16) | $ (0.83) |
| Weighted average common shares outstanding | ||||
| Basic | 39,615,815 | 14,141,443 | 39,615,815 | 11,844,024 |
| Diluted | 39,615,815 | 14,141,443 | 39,615,815 | 11,844,024 |
| X | ||||||||||
- Definition Change in fair value of warrant liability. No definition available.
|
| X | ||||||||||
- Definition Gain loss on conversion of note payable. No definition available.
|
| X | ||||||||||
- Definition Loss on disposition of subsidiaries. No definition available.
|
| X | ||||||||||
- Definition Technology expense. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|